Quantcast
Last updated on April 16, 2014 at 10:37 EDT

Luminex Corporation To Present At Leerink Swann Global Healthcare Conference

January 31, 2013

AUSTIN, Texas, Jan. 31, 2013 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Leerink Swann Global Healthcare Conference to be held February 13 -14, 2013, in New York, NY.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 11:30 a.m. Eastern time on Thursday, February 14, 2013. The presentation will be webcast live and may be accessed at Luminex Corporation’s website at http://www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the ‘replay’ link.

ABOUT LUMINEX CORPORATION

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP(®) open-architecture, multi-analyte platform and MultiCode(®) real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex’s technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.

    Contacts:                  Harriss T. Currie
                               Chief Financial Officer
                               Vice President Finance
                               512-219-8020

                               Matthew Scalo
                               Sr. Director of Investor Relations
                               512-219-8020
                               mscalo@luminexcorp.com

SOURCE Luminex Corporation


Source: PR Newswire